Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

HP Arize 3D Orthotics for Planar Fasciitis

NCT: NCT05707013 · ACTIVE_NOT_RECRUITING

NCT IDNCT05707013
StatusACTIVE_NOT_RECRUITING
Start Date2023-01-19
Completion2026-12-31
SponsorPrisma Health-Midlands (OTHER)
First posted
Last updated

Brief Summary

Currently 77% of Americans experience foot pain, of which a large portion can be attributed to plantar fasciitis. The Arize Orthotic solution, developed in collaboration with podiatrists and leading industry experts, is a new digital solution that helps podiatrists create custom foot orthoses tailored to the patient, quickly, easily, accurately, and reliably. This pilot study will evaluate the effectiveness and clinical benefit of 3D printed foot orthotics compared to traditionally fabricated custom-made orthotics and assess compliance and patient satisfaction in patients with plantar fasciitis.

Frequently Asked Questions

What is HP Arize 3D Orthotics for Planar Fasciitis?

HP Arize 3D Orthotics for Planar Fasciitis is a clinical trial registered under NCT05707013. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05707013?

The current status of NCT05707013 (HP Arize 3D Orthotics for Planar Fasciitis) is: ACTIVE_NOT_RECRUITING.

When did HP Arize 3D Orthotics for Planar Fasciitis start?

HP Arize 3D Orthotics for Planar Fasciitis started on 2023-01-19.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.